0.423
price down icon2.76%   -0.012
 
loading
전일 마감가:
$0.435
열려 있는:
$0.42
하루 거래량:
350.29K
Relative Volume:
0.17
시가총액:
$17.73M
수익:
$62.71M
순이익/손실:
$-10.48M
주가수익비율:
-0.6714
EPS:
-0.63
순현금흐름:
$-13.77M
1주 성능:
+13.28%
1개월 성능:
+20.86%
6개월 성능:
-21.67%
1년 성능:
-86.40%
1일 변동 폭
Value
$0.4146
$0.4394
1주일 범위
Value
$0.3525
$0.445
52주 변동 폭
Value
$0.2179
$3.3654

프로페이즈 Stock (PRPH) Company Profile

Name
명칭
Prophase Labs Inc
Name
전화
(215) 345-0919
Name
주소
711 STEWART AVE, SUITE 200, NEW YORK, PA
Name
직원
96
Name
트위터
Name
다음 수익 날짜
2025-05-20
Name
최신 SEC 제출 서류
Name
PRPH's Discussions on Twitter

PRPH을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Diagnostics & Research icon
PRPH
Prophase Labs Inc
0.4269 16.22M 62.71M -10.48M -13.77M -0.63
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
478.83 161.42B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
203.79 135.99B 24.01B 3.41B 4.86B 4.70
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
546.27 42.78B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
202.32 31.85B 15.50B 1.33B 2.16B 7.34
Diagnostics & Research icon
A
Agilent Technologies Inc
120.50 33.01B 6.63B 1.17B 1.19B 4.05

프로페이즈 Stock (PRPH) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2021-12-20 개시 H.C. Wainwright Buy
2021-10-13 다운그레이드 Dawson James Buy → Neutral
2021-01-20 개시 Dawson James Buy

프로페이즈 주식(PRPH)의 최신 뉴스

pulisher
04:14 AM

ProPhase Labs shares rise 1.15% premarket after closing $3 million senior secured convertible notes financing. - AInvest

04:14 AM
pulisher
12:29 PM

What analysts say about ProPhase Labs Inc. stockOutstanding capital appreciation - jammulinksnews.com

12:29 PM
pulisher
Jul 23, 2025

ProPhase Labs Announces Closing of $3 Million Senior Secured Convertible Notes Financing - GlobeNewswire

Jul 23, 2025
pulisher
Jul 23, 2025

ProPhase Labs secures $3 million in convertible notes financing - Investing.com India

Jul 23, 2025
pulisher
Jul 23, 2025

Prophase Labs Secures $3 Million in Private Financing - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

ProPhase Labs Raises $3M as Bridge to $50M Covid Collections and Crypto Strategy Launch - Stock Titan

Jul 23, 2025
pulisher
Jul 22, 2025

What drives ProPhase Labs Inc. stock priceUnprecedented profits - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

ProPhase Labs Board of Directors Authorizes Management to - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

Why ProPhase Labs Inc. stock attracts strong analyst attentionBreakout Momentum Stocks - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Is ProPhase Labs Inc. a good long term investmentDynamic growth stocks - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

ProPhase Labs Inc. Stock Analysis and ForecastUnbelievable profit margins - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Prophase Labs Explores Reverse Merger with Digital Asset Firm - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

ProPhase Labs explores reverse merger with digital asset company - Investing.com

Jul 21, 2025
pulisher
Jul 21, 2025

ProPhase Labs explores strategic reverse merger and approves crypto treasury initiative. - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

ProPhase Labs Board of Directors Authorizes Management to Explore Strategic Reverse Merger and Approves Crypto Treasury Initiative - The Globe and Mail

Jul 21, 2025
pulisher
Jul 21, 2025

ProPhase Labs Makes Bold Crypto Move: Plans Reverse Merger While Protecting $50M Healthcare Portfolio - Stock Titan

Jul 21, 2025
pulisher
Jul 20, 2025

What makes ProPhase Labs Inc. stock price move sharplyHigh Potential Safe Trades - beatles.ru

Jul 20, 2025
pulisher
Jul 16, 2025

Prophase Labs shares rise 1.88% after-hours following an investor presentation. - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Prophase Labs shares fall 10.58% intraday after investor presentation. - AInvest

Jul 16, 2025
pulisher
Jul 15, 2025

How ProPhase Labs Inc. stock performs during market volatilityFree Stock Portfolio Optimization - Newser

Jul 15, 2025
pulisher
Jul 02, 2025

ProPhase Labs Regains Nasdaq Compliance with New Appointment - The Globe and Mail

Jul 02, 2025
pulisher
Jul 01, 2025

PCSA ends Ocuphire licensing deal, starts portfolio review – Form 8-K - Stock Titan

Jul 01, 2025
pulisher
Jun 26, 2025

Prophase Labs Secures $1M in New Loan Agreements - TipRanks

Jun 26, 2025
pulisher
Jun 26, 2025

ProPhase Labs, Inc. Receives Additional 180 Day Extension from N - GuruFocus

Jun 26, 2025
pulisher
Jun 26, 2025

ProPhase Labs, Inc. Receives Additional 180 Day Extension - GlobeNewswire

Jun 26, 2025
pulisher
Jun 26, 2025

ProPhase Labs Given 180-Day Extension by Nasdaq to Regain Compliance With $1 Minimum Bid Price Rule - MarketScreener

Jun 26, 2025
pulisher
Jun 25, 2025

Prophase Labs Appoints Carolina Abenante as Director - TipRanks

Jun 25, 2025
pulisher
Jun 25, 2025

ProPhase Labs appoints Carolina Abenante as independent director By Investing.com - Investing.com UK

Jun 25, 2025
pulisher
Jun 21, 2025

ProPhase Labs, Inc. announced that it expects to receive $0.5 million in funding - MarketScreener

Jun 21, 2025
pulisher
Jun 17, 2025

ProPhase Labs Announces Successful Study Demonstrating Performan - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

ProPhase Labs (PRPH) Advances with Positive Validation of BE-Smart Test | PRPH Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Prophase Labs Announces Successful Study Demonstrating Performance Of Be-Smart(TM) Test In Detecting Esophageal Cancer - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

ProPhase Labs Inc. Validates BE-Smart™ Diagnostic Test for Esophageal Disease with Over 95% Success Rate - Nasdaq

Jun 17, 2025
pulisher
Jun 17, 2025

ProPhase Labs Announces Successful Study Demonstrating - GlobeNewswire

Jun 17, 2025
pulisher
Jun 17, 2025

Breakthrough: ProPhase's New Cancer Test Shows 95% Success Rate, Targets $10B Market - Stock Titan

Jun 17, 2025
pulisher
Jun 16, 2025

ProPhase Labs Inc (PRPH)’s Market Momentum: Closing Strong at 0.33, Down -2.56 - DWinneX

Jun 16, 2025
pulisher
Jun 11, 2025

ProPhase Labs, Inc. (NASDAQ:PRPH) Q1 2025 Earnings Call Transcript - MSN

Jun 11, 2025

프로페이즈 (PRPH) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
diagnostics_research WAT
$298.01
price up icon 0.81%
$137.42
price down icon 0.31%
diagnostics_research DGX
$171.57
price up icon 0.57%
diagnostics_research LH
$267.77
price up icon 6.94%
diagnostics_research MTD
$1,253.23
price down icon 0.14%
diagnostics_research A
$120.52
price up icon 0.84%
자본화:     |  볼륨(24시간):